Molecular Characterization of Multiple Myeloma Ethnic Disparity


The goal of this funding opportunity is to determine the molecular characteristics of Multiple Myeloma (MM) in patients of Black ethnicity compared to those of White ethnicity. The project will support the FDA's scientific mission of protecting and promoting the public health by initiating and facilitating research into the observed differences in Blacks and the relevance to drug approval and future clinical trial design.

General information about this opportunity
Last Known Status
Deleted 08/20/2015 (Archived.)
Program Number
Federal Agency/Office
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Type(s) of Assistance Offered
Cooperative Agreement
Number of Awards Available
Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Eligibility is limited to the Multiple Myeloma (MM) service of Memorial Sloan Kettering Cancer Institute.
What is the process for applying and being award this assistance?
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Headquarters Office
Vieda Hubbard
Grants Management Specialist
Phone 240-402-7588
E-mail Address
Financial Information
Range and Average of Financial Assistance
Awards range from $172,000.00 to $172,000.00


Related Federal Grants

Federal Grants Resources